Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation (Q28207989)
Jump to navigation
Jump to search
scientific article (publication date: 15 July 2001)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation |
scientific article (publication date: 15 July 2001) |
Statements
Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation (English)
0 references
15 July 2001
0 references
92
0 references
2
0 references
406-13
0 references